Evidence map›Paper›PMID 20385880›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2010

T cell pathways involving CTLA4 contribute to a model of acute lung injury.

Takeshi Nakajima, Carlos Jose Suarez, Ko-Wei Lin, Kai Yu Jen, Jan E Schnitzer, Samir S Makani, Nathan Parker, David L Perkins, Patricia W Finn

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 56 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Gut-derived immune cells and the gut-lung axis in ARDS.Critical care (London, England) · 2024
    Review
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Cell type-specific immune dysregulation in severely ill COVID-19 patients.medRxiv : the preprint server for health sciences · 2020
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Takeshi NakajimaDivision of Pulmonary and Critical Medicine, Department of Medicine, University of California, San Diego, La Jolla, CA 92093, USA.
Carlos Jose Suarez
Ko-Wei Lin
Kai Yu Jen
Jan E Schnitzer
Samir S Makani
Nathan Parker
David L Perkins
Patricia W Finn
Pulmonary Associates · USUniversity of California San Diego · USProteogenomics Research Institute for Systems Medicine · US

Funding

Innate Immunity and Allergy: Modulation by CTLA4R01HL081663 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FINN, PATRICIA W · 2005 to 2008
$2.0M
NHLBI NIH HHS 5R01HL081663-05NHLBI NIH HHS R01 HL081663
6 · The paper itself

Abstract

Acute lung injury (ALI) is a frequent pulmonary complication in critically ill patients. We characterized a murine model of LPS-induced ALI, focusing on Th cells. Following LPS administration, bronchoalveolar lavage lymphocytes, neutrophils, IL-6, TNF-alpha, and albumin were increased. Analysis of LPS-induced T cells revealed increased Th cell-associated cytokines (IL-17A, -17F, and -22), as well as increased expression of CD69 (a cell activation marker), Foxp3, and CTLA4 in CD4(+) T cells. Administration of anti-CTLA4 Ab decreased LPS-induced bronchoalveolar lavage albumin and IL-17A, while increasing CD4(+)Foxp3(+) cell number and Foxp3 expression in CD4(+)Foxp3(+) cells. These data suggest that pulmonary LPS administration promotes CD4(+) T cells and that T cell pathways involving CTLA4 contribute to ALI.

Indexed as

Disease Models, AnimalAcute Lung InjuryAnimalsAntibodies, MonoclonalAntigens, CDB-Lymphocyte SubsetsCTLA-4 AntigenFemaleInflammation MediatorsLipopolysaccharidesLymphocyte CountLymphopeniaMiceMice, Inbred BALB CMice, KnockoutSeverity of Illness IndexAntibodies, MonoclonalAntigens, CDCTLA-4 AntigenCtla4 protein, mouseInflammation MediatorsLipopolysaccharides

Identifiers

PMID20385880
PMCPMC3068917
OpenAlexW1911263523

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.